Precision Biosciences (DTIL) EBT (2018 - 2026)
Precision Biosciences' (DTIL) quarterly EBT came in at -$8.6 million in Q1 2026, up 59.69% year-on-year from -$5.4 million in Q1 2025, and down 169.19% on a QoQ basis from $12.4 million in Q4 2025.
Precision Biosciences (DTIL) EBT (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of EBT data on file, last reported at -$8.6 million in Q1 2026.
- On a quarterly basis, EBT rose 59.69% year-over-year to -$8.6 million in Q1 2026; TTM through Mar 2026 was -$46.0 million, a 22.07% increase from a year earlier, with the FY2025 full-year figure at -$193.2 million, down 23.62% from the prior year.
- EBT for Q1 2026 stood at -$8.6 million, down from $12.4 million in the prior quarter.
- Over the last five years, EBT for DTIL reached as high as $15.6 million in Q2 2024 and fell as low as -$35.9 million in Q2 2022.
- Historically, EBT has averaged -$14.6 million across 5 years, with a median of -$13.8 million in 2023.
- Across the five-year window, EBT surged 305.3% in 2024 and plunged 586.67% in 2025, its largest moves.
- Year by year, EBT stood at -$12.0 million in 2022, then retreated by 14.88% to -$13.8 million in 2023, then sank by 72.8% to -$23.8 million in 2024, then soared by 151.96% to $12.4 million in 2025, then tumbled by 169.19% to -$8.6 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$8.6 million in Q1 2026, $12.4 million in Q4 2025, and -$27.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | -8.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.58 Mn |
| Dec 31, 2025 | 12.39 Mn |
| Sep 30, 2025 | -27.65 Mn |
| Jun 30, 2025 | -22.17 Mn |
| Mar 31, 2025 | -21.27 Mn |
| Dec 31, 2024 | -23.85 Mn |
| Sep 30, 2024 | -29.46 Mn |
| Jun 30, 2024 | 15.57 Mn |
| Mar 31, 2024 | -3.10 Mn |
| Dec 31, 2023 | -13.80 Mn |
| Sep 30, 2023 | -10.79 Mn |
| Jun 30, 2023 | -7.58 Mn |
| Mar 31, 2023 | -11.88 Mn |
| Dec 31, 2022 | -12.01 Mn |
| Sep 30, 2022 | -14.03 Mn |
| Jun 30, 2022 | -35.86 Mn |
| Mar 31, 2022 | -34.23 Mn |
| Dec 31, 2021 | -30.76 Mn |
| Sep 30, 2021 | -22.12 Mn |
| Jun 30, 2021 | 19.55 Mn |